TrialJournal of acquired immune deficiency syndromes (1999)2014

HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.

George E Woody et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.